Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02964442
Other study ID # 2015/00715
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date October 23, 2015
Est. completion date October 24, 2023

Study information

Verified date May 2024
Source Clinical Nutrition Research Centre, Singapore
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Brown adipose tissue (BAT) thermogenesis can be assessed by IR thermography, the accompanying increase metabolic rate can be measured by whole body calorimetry and BAT volume can be precisely measured by MRI. The aim of the study is to validate IRT for BAT thermogenesis against the present gold standard 18-FDG-PET scan, quantify BAT volume by fat fraction MRI and measure the accompanying increase in BMR by whole body calorimetry among healthy euthyroid subjects.


Description:

It is now known that human adults do possess viable brown fat in quantities that may be critical for maintenance of a normal basal metabolic rate (BMR) and body weight, dispelling the myth that BAT is only present during infancy for thermoregulation. There are data suggesting that obesity is associated with insufficient BAT. So far the only known and arguably 'gold standard' methodology of BAT imaging in humans is 18-FDG-PET. Yet 18-FDG-PET imaging has significant limitations, given its restricted spatial resolution and its non-trivial level of ionizing radiation (2.8 mSv). The International Commission for Radiological Protection recommends that the radiation exposure for the general public should not exceed 1mSv/year and 1.5 mSv/year from background radiation. In addition, 18-FDG-PET depends on glucose uptake by BAT that does not directly measure its key metabolic activity, namely fatty acid oxidation. Finally, PET scans are very costly. This makes the present gold standard far from ideal as a research tool for investigating BAT physiology. Thus the first objective of this project is to develop an alternative activated BAT imaging method that is not based on ionizing radiation. We are interested in advancing infrared (IR) thermography as a method to assess BAT activity by developing a novel image processing algorithms for IR thermography. Much extant literature describes the use of "average temperature" instead of IR heat flux using the physical principles of radiative heat transfer and thermodynamics to quantify heat from BAT. Also,IR digital still-shots were mostly employed in the past whereas none have reported the analysis of IR flux using a video sequence which more accurately integrates time-varying heat energy output. Without precision in capturing and processing the rich IR data, the value of IR thermography as a tool for BAT research is limited. It is thus crucial to convert the IR images into a readout that reflects energy output. We will thus develop, validate and apply automatic IR image processing with computer software that can efficiently calculate BAT activation. In this proposal we will also improve and validate anatomical fat fraction MRI as a tool for evaluating BAT volumes based on the higher water content in BAT compared with that in WAT. Fat fraction imaging by MRI has been proposed but no proper validation has been done due to the difficulty in matching PET and MRI data on BAT. Instead of using pharmacologic agents (e.g. beta 3-adrenergic receptor agonists such as mirabegron) that can be administered to activate BAT instead of cold stimulus, we will employ capsiate (i.e. capsinoids - non-spicy analogues of capsaicin in peppers and chilies) that have been proven to effectively stimulate BAT in thermoneutral conditions as confirmed by PET scans. We have conducted a preliminary study approved by the DSRB that showed the effectiveness of capsinoids in stimulating BAT. There are publications documenting the use of MRI in distinguishing BAT from WAT, each with their advantages and disadvantages. In this present study, we will perform a proof-of-concept study by simultaneous acquisition of MRI and 18-FDG-PET in a dual-modality fusion MRI-PET scanner available at the Clinical Imaging Research Centre (CIRC) to image BAT in humans, and correlate this with IR thermography of the cervical and supraclavicular regions (SCR) and with metabolic rate accurately measured in a whole body calorimeter. Whole body calorimetry is the real gold standard to assess BAT activity by measuring nonshivering thermogenesis. IR has so far been validated against 18-FDG-PET in mice and rodents, but equivalent validation in humans has not been published. If IR thermography is shown to be equivalent or superior to 18-FDG-PET imaging, it will set a new gold standard in BAT imaging which will be a boon for study of BAT biology in humans.


Recruitment information / eligibility

Status Completed
Enrollment 30
Est. completion date October 24, 2023
Est. primary completion date October 24, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 21 Years to 40 Years
Eligibility Inclusion Criteria: - Overtly healthy with no past history of chronic illnesses - Aged 21-40 years old Male and female gender - BMI from 18.5 to 29.9 kg/m2 inclusive - No prior history of thyroid disease. - Euthyroid biochemically with FT4 and TSH in the normal ranges Exclusion Criteria: - Recent changes in weight of >5% over the past 6 months. - Attempts to lose weight over the past 6 months. - Significant changes in diet over the past 6 months. - Any use of weight reducing drugs in the past 6 months. - Previous weight reducing surgery. - Any use of investigational drugs in the past 6 months. - Subclinical thyroid dysfunction based on thyroid function test. - Chronic illnesses such as diabetes mellitus or cancer. - You have a known history of thyroid, liver or kidney disease. - Use of any prescription medication that cannot be safely discontinued within 14 days prior to study entry. - Female subjects who are pregnant. - Oral medications affecting brown fat activity (eg. alpha agonists or blockers, beta agonists or blockers, sympatholytic agents) which the researchers will clarify with you. - Chronic topical ointment with menthol or capsaicin or use of nasal decongestants. - History of surgery with metallic clips, staples or stents. - Presence of cardiac pacemaker or other foreign body in any part of the body. - History of claustrophobia particularly in a MRI scanner. - Had a PET scan done within the past 4 months.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Capsinoids
12 mg of Gel capsules
Cold Stimulus
Cooling vest maintain at 14 degree Celsius

Locations

Country Name City State
Singapore Clinical Nutrition Research Centre Singapore

Sponsors (2)

Lead Sponsor Collaborator
Clinical Nutrition Research Centre, Singapore Institute of Bioengineering and Bioimaging (IBB)

Country where clinical trial is conducted

Singapore, 

Outcome

Type Measure Description Time frame Safety issue
Primary Brown adipose tissue activation detection by Imaging using 18-FDG-PET/ MRI. post consumption of capsinoids capsules for 2 hours
Primary Energy Expenditure using Whole Body Calorimeter. post consumption of capsinoids capsules for 2 hours
Primary Brown adipose tissue activation detection by Imaging using Infrared Thermography. post consumption of capsinoids capsules for 2 hours
Secondary Brown adipose tissue activation detection by Imaging using 18-FDG-PET/ MRI. post cold stimulus up to 2 hours
Secondary Energy Expenditure using Whole Body Calorimeter. To measure cold stimulus for 2 hours
Secondary Brown adipose tissue activation detection by Imaging using Infrared Thermography. post cold stimulus up to 2 hours
See also
  Status Clinical Trial Phase
Completed NCT02038595 - The Norepinephrine Transporter: A Novel Target for Imaging Brown Adipose Tissue Early Phase 1
Recruiting NCT06078345 - Brown Adipose Tissue as Nutrient Buffer Through Diet Induced Thermogenesis N/A
Active, not recruiting NCT03541096 - Winter-Swimming and Brown Adipose Tissue Activity in Middel-aged Obese Subjects (WinterBAT). N/A
Completed NCT04766021 - Mirabegron and Physiological Function in Cold Environments Phase 1/Phase 2
Completed NCT01898949 - Stimulation of Diet-Induced Thermogenesis by Cold-Exposure N/A
Recruiting NCT05711199 - Effect of Glyceroltrinitrate on Human Energy Expenditure and Brown Adipose Tissue Thermogenesis Early Phase 1
Completed NCT05990387 - MIrabegron and Physiological Function in Cold Environments Phase 1/Phase 2
Recruiting NCT04595006 - Brown Fat Activation and Browning Efficiency Augmented by Chronic Cold and Nutraceuticals for Brown Adipose Tissue-mediated Effect Against Metabolic Syndrome (BEACON BEAMS Study) N/A
Completed NCT02381483 - Vitamin A in Brown Fat Activity N/A
Completed NCT03269747 - Short Term Effect of Glucocorticoids on Brown Adipose Tissue Thermogenesis in Humans Phase 4
Recruiting NCT05517967 - An Examination of Brown Adipose Tissue and Energy Expenditure in Infants
Completed NCT03490227 - Measurement of Body Fat in Infants
Completed NCT03095846 - Cold Induced Activation of Brown Adipose Tissue in Winter Swimmers N/A
Completed NCT03096535 - Cold Induced Activation of Brown Adipose Tissue in Humans N/A